Home Slider

Welcome to Aurobindo Pharma USA: Committed to healthier life.

Product News

Aurobindo Receives FDA Approval for Quetiapine Fumarate Extended Release Tablets.

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from the U.S. Food and Drug Administration for Quetiapine Fumarate Extended-Release Tablets, 50 mg, 150 mg, 200 mg, 300mg and 400mg. The Division of Bioequivalence has determined Aurobindo Pharma Limited’s Quetiapine Fumarate Extended-Release Tablets 50 mg, 150 mg, 200 mg, 300 mg, and 400

[...] Read more

Industry News

Aurobindo wins Company of the Year, Asia-Pacific Award at the Global Generics & Biosimilars Awards 2017

Frankfurt, 24 October 2017 – Aurobindo Pharma Limited and Generics Bulletin are pleased to announce that Aurobindo has won the Company of the Year, Asia-Pacific Award at the Global Generics & Biosimilars Awards 2017, organized by Generics Bulletin. The Company of the Year, Asia-Pacific Award was sponsored by Eva Pharma and judged by an expert panel. “Congratulations

[...] Read more

Social Responsibility

Dispensary of Hope

Aurobindo became a partner to Dispensary of Hope in 2012. In only 5 short years, Aurobindo has donated 3,736,413 doses of medicine. Almost 30% of these doses were donated in 2017. This is largely due to the quick and additional response to Hurricane Harvey relief efforts with additional donations. Pharmaceutical products are provided to the

[...] Read more